[Lab] split one vial across Medutest and Janoshik — 96.2% and 99.2%
I have had 19 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied by about 32 days on nominally the same lane, which matters more in summer than in February. The independent number came back 99.0% against a claimed…
What was the dosing schedule in that arm?
[removed by moderator]
the 2.5mg arm is different from 5mg, results do not transfer
triple agonism is phase 2, do not generalise
[removed by moderator]
Adding to this: dose escalation is doing more work than the comment implies.
the weight curves are unusually steep, which makes predicting individual response harder
research use only, handling and analysis, not protocols
The confident tone is doing a lot of work that the evidence is not.
The confident tone is doing a lot of work that the evidence is not.
Adding to this: triple agonist is doing more work than the comment implies.
research use only, handling and analysis, not protocols
Respectfully this is a sample of one presented as a finding.
Respectfully this is a sample of one presented as a finding.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
the glucagon component changes the side effect profile, not just the efficacy
retatrutide is not approved anywhere for human use, posts must not read as instructions